Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2022 Mar; 29(3):2089-2099.

View in: PubMed

subject areas

Adult
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Cancer, Regional Perfusion
Cohort Studies
Combined Modality Therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermia, Induced
Prognosis
Retrospective Studies
Survival Rate

authors with profiles

JUAN P CATA
PASCAL OWUSU-AGYEMANG
KEITH FRANCIS FOURNIER